Published in Anal Biochem on March 01, 1977
Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell (2001) 2.44
High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol Cell Biol (1998) 2.38
The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J Biol Chem (1998) 2.08
Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Infect Immun (1983) 1.95
The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol Cell Biol (2000) 1.83
Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J Biol Chem (1992) 1.70
The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences. Mol Cell Biol (1994) 1.65
Following anterior resection for rectal cancer, defunctioning ileostomy closure may be significantly delayed by adjuvant chemotherapy: a retrospective study. Colorectal Dis (2007) 1.54
Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer. Cancer Res (1986) 1.53
Determination of the glycosylated hemoglobins (HB AI) with a new microcolumn procedure. Suitability of the technique for assessing the clinical management of diabetes mellitus. Diabetes (1978) 1.51
Varicella-zoster virus-specific gp140: a highly immunogenic and disulfide-linked structural glycoprotein. Virology (1984) 1.49
Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody. Mol Endocrinol (2000) 1.39
Human progesterone receptor complexed with the antagonist RU 486 binds to hormone response elements in a structurally altered form. Mol Endocrinol (1989) 1.29
Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. Mol Endocrinol (1999) 1.23
Estrogen induced synthesis of specific proteins in human breast cancer cells. Biochem Biophys Res Commun (1980) 1.22
Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo. Mol Endocrinol (1997) 1.22
Effect of pH on the binding of theophylline to serum proteins. Am Rev Respir Dis (1979) 1.18
The validation of new aromatase monoclonal antibodies for immunohistochemistry--a correlation with biochemical activities in 46 cases of breast cancer. J Steroid Biochem Mol Biol (2005) 1.18
Estrogen and progesterone receptor proteins in breast cancer. Biochim Biophys Acta (1979) 1.16
Estrogen regulation of specific messinger RNA's in human breast cancer cells. Biochem Biophys Res Commun (1980) 1.16
Coregulatory proteins in steroid hormone receptor action: the role of chromatin high mobility group proteins HMG-1 and -2. Steroids (1999) 1.15
Identification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites. J Biol Chem (2000) 1.13
Immunologic analysis of human breast cancer progesterone receptors. 1. Immunoaffinity purification of transformed receptors and production of monoclonal antibodies. Biochemistry (1987) 1.13
Dimerization of mammalian progesterone receptors occurs in the absence of DNA and is related to the release of the 90-kDa heat shock protein. Proc Natl Acad Sci U S A (1991) 1.13
Distribution of an estrogen-induced protein with a molecular weight of 24,000 in normal and malignant human tissues and cells. Cancer Res (1983) 1.13
Ligands induce conformational changes in the carboxyl-terminus of progesterone receptors which are detected by a site-directed antipeptide monoclonal antibody. Mol Endocrinol (1992) 1.11
A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1) Mol Endocrinol (1999) 1.10
A quantitative comparison of dual control of a hormone response element by progestins and glucocorticoids in the same cell line. Mol Endocrinol (1989) 1.09
The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. Proc Natl Acad Sci U S A (1993) 1.08
Improving exposure and safety at the saphenofemoral junction. Ann R Coll Surg Engl (1995) 1.07
Gastrointestinal haemorrhage after abdominal aortic grafting. J R Soc Med (1999) 1.06
Identification of a group of Ser-Pro motif hormone-inducible phosphorylation sites in the human progesterone receptor. Mol Endocrinol (1995) 1.04
Metyrosine and pheochromocytoma. Arch Intern Med (1997) 1.02
A sequence in the 5' flanking region confers progestin responsiveness on the human c-myc gene. J Steroid Biochem Mol Biol (1997) 1.02
Steroid hormone-dependent interaction of human progesterone receptor with its target enhancer element. Mol Endocrinol (1988) 1.01
Monoclonal antibody storage conditions, and concentration effects on immunohistochemical specificity. J Histochem Cytochem (1983) 1.01
Detection of a Mr 24,000 estrogen-regulated protein in human breast cancer by monoclonal antibodies. Cancer Res (1983) 1.00
The constitution of a progesterone response element. Mol Endocrinol (1993) 1.00
Human sperm plasma membrane progesterone receptor(s) and the acrosome reaction. Biol Reprod (1996) 0.99
Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors. Mol Endocrinol (1992) 0.99
Liquid scintillation counting of (3H) and (14C) on solid supports: a warning. Anal Biochem (1970) 0.99
Interaction of the progesterone receptor with binding proteins for FK506 and cyclosporin A. Mol Endocrinol (1995) 0.99
The 5'-flanking region of the ovine follicle-stimulating hormone-beta gene contains six progesterone response elements: three proximal elements are sufficient to increase transcription in the presence of progesterone. Endocrinology (1995) 0.99
Rectovaginal fistula in Crohn's disease. Dis Colon Rectum (2007) 0.99
Identification of phosphorylation sites unique to the B form of human progesterone receptor. In vitro phosphorylation by casein kinase II. J Biol Chem (1994) 0.97
Phosphorylation and progesterone receptor function. J Steroid Biochem Mol Biol (1995) 0.97
The high mobility group protein 1 enhances binding of the estrogen receptor DNA binding domain to the estrogen response element. Mol Endocrinol (1998) 0.97
Characterization and functional properties of the A and B forms of human progesterone receptors synthesized in a baculovirus system. Mol Endocrinol (1991) 0.96
Progesterone regulates proliferation of endothelial cells. J Biol Chem (1999) 0.96
Apparent irrelevance of cyclic nucleotides to the relaxation of tracheal smooth muscle induced by theophylline. Lung (1979) 0.95
17 alpha-Estradiol is a biologically active estrogen in human breast cancer cells in tissue culture. Endocrinology (1980) 0.94
Estradiol stimulates synthesis of a major intracellular protein in a human breast cancer cell line (MCF-7). Breast Cancer Res Treat (1981) 0.94
Validation of new aromatase monoclonal antibodies for immunohistochemistry: progress report. J Steroid Biochem Mol Biol (2003) 0.93
Measurement of 131 I and 125 I by liquid scintillation counting. Anal Biochem (1972) 0.93
The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation. Endocrinology (1998) 0.91
Structural analysis of chicken oviduct progesterone receptor using monoclonal antibodies to the subunit B protein. Biochemistry (1984) 0.90
Management of the rectal stump after emergency sub-total colectomy: which surgical option is associated with the lowest morbidity? Colorectal Dis (2005) 0.90
Hinge and amino-terminal sequences contribute to solution dimerization of human progesterone receptor. Mol Endocrinol (1997) 0.89
Small fragment wounds: biophysics, pathophysiology and principles of management. J R Army Med Corps (2001) 0.89
Progesterone receptor-induced bending of its target DNA: distinct effects of the A and B receptor forms. Mol Endocrinol (1996) 0.89
Two types of anti-progestins have distinct effects on site-specific phosphorylation of human progesterone receptor. J Biol Chem (1996) 0.88
Immunologic analysis of human breast cancer progesterone receptors. 2. Structure, phosphorylation, and processing. Biochemistry (1987) 0.88
Immunohistochemical detection of an estrogen-regulated protein by monoclonal antibodies. Cancer Res (1982) 0.87
Nuclear accessory factors enhance the binding of progesterone receptor to specific target DNA. J Steroid Biochem Mol Biol (1994) 0.87
Stoichiometry and site-specific phosphorylation of human progesterone receptor in native target cells and in the baculovirus expression system. J Biol Chem (1996) 0.87
Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay. Mol Endocrinol (1998) 0.87
16 alpha-substituted analogs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity. Proc Natl Acad Sci U S A (1996) 0.86
Expression and purification of recombinant human progesterone receptor in baculovirus and bacterial systems. Methods Mol Biol (2001) 0.84
Estrogen-induced 24K protein in MCF-7 breast cancer cells is localized in granules. Breast Cancer Res Treat (1984) 0.84
A 361 base pair region of the rat FSH-beta promoter contains multiple progesterone receptor-binding sequences and confers progesterone responsiveness. Mol Cell Endocrinol (1997) 0.84
Molecular cloning of a cDNA for the chicken progesterone receptor B antigen. Proc Natl Acad Sci U S A (1984) 0.84
Evidence that heat shock protein-70 associated with progesterone receptors is not involved in receptor-DNA binding. Mol Endocrinol (1991) 0.84
The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors. Endocrinology (1993) 0.84
Subcellular compartmentalization of estrogen receptors in human breast cancer cells. Exp Cell Res (1980) 0.83
Direct binding of progesterone receptor to nonconsensus DNA sequences represses rat GnRH. Mol Cell Endocrinol (1996) 0.83
Primary culture and maintenance of steroid-secreting human placenatal monolayers. In Vitro (1976) 0.83
Immunological detection of Chinese hamster ovary cells expressing a multidrug resistance phenotype. Cancer Res (1985) 0.83
Effects of the steroid antagonist RU486 on dimerization of the human progesterone receptor. Biochemistry (1992) 0.83
Cloud Detection and Clearing for the Earth Observing System Terra Satellite Measurements of Pollution in the Troposphere (MOPITT) Experiment. Appl Opt (2001) 0.83
Estrogen regulation of specific proteins as a mode of hormone action in human breast cancer. Biomembranes (1983) 0.82
Adenosine 3',5'-monophosphate, adrenocorticotropic hormone, and adrenocortical cytosol protein synthesis. Science (1970) 0.81
Crown ethers which influence cardiac and respiratory muscle contractility. Experientia (1984) 0.81
Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies. Cancer Res (1988) 0.81
Specific protein synthesis regulated by estrogen in human breast cancer. J Steroid Biochem (1981) 0.80
Immunologic detection of a protein homologous to chicken progesterone receptor B subunit. J Biol Chem (1985) 0.80
Human placental 3beta-hydroxysteroid dehydrogenase: delta5-isomerase. Demonstration of an intermediate in the conversion of 3beta-hydroxypregn-5-en-20-one to pregn-4-ene-3,20-dione. J Biol Chem (1976) 0.80
Actinomycin D in vivo: paradoxical and nonspecific effects on adrenal cortex. Endocrinology (1969) 0.79
Regulation of anterior pituitary gonadotropin subunit mRNA levels during the preovulatory gonadotropin surge: a physiological role of progesterone in regulating LH-beta and FSH-beta mRNA levels. J Steroid Biochem Mol Biol (1993) 0.79
Letter: Ureterosigmoidostomy and cancer: new observations. Ann Intern Med (1975) 0.79
Failure of estradiol immunofluorescence in MCF-7 breast cancer cells to detect estrogen receptors. Cancer Res (1981) 0.79
Estrogen regulation of growth and specific protein synthesis in human breast cancer cells in tissue culture. Adv Exp Med Biol (1981) 0.79
An immunotoxin cytotoxic for breast cancer cells in vitro. Cancer Res (1987) 0.78
Estrogen action in human breast cancer (review). Anticancer Res (1983) 0.78
Effects of estrogen and antiestrogen on DNA polymerase in human breast cancer. Cancer Res (1980) 0.78
Hypoglycemia caused by selegiline, an antiparkinsonian drug: can such side effects be predicted? J Clin Pharmacol (1994) 0.78
Adrenal cortex. Annu Rev Physiol (1968) 0.78
Comparison of the effect of ACTH and an inhibitor of 3-beta-hydroxysteroid dehydrogenase on the synthesis of adrenal microsomal proteins. J Clin Endocrinol Metab (1969) 0.78
Estrogen-regulated protein in human breast cancer. J Steroid Biochem (1984) 0.77